There will probably be SMI-only users left but it will be hard to track results. Many prefer cocktailsHey, are all of you guys are planning to add WAY and ARV? So there will be no SMI-only user left?
Great, count me inYes, no need to buy both. They are separate buys being conducted at the same time
There will probably be SMI-only users left but it will be hard to track results. Many prefer cocktails
ARs play many important roles in the body, but you're only targeting those in the hair follicles, which are overexpressed compared to non-balding follicles anyway.Can someone explain how an AR degrader won't be really bad for you?
Looking it up, ARs play a role as a DNA binding transcription factor. Would this effect gene expression in our cells? What are the consequences?
Pretty sure all of this buys are from China.Important question: For people who live within the EU, will the package be send from a country within EU or outside of EU. Customs will f*** me hard if it's from outside EU like China .......
I will maybe join after I see the first results from other people.
Base on the fact only 1 person shared results , and the result were meh. I would say dont hold your breath for it.
Dude he was on SMI only and regrew terminals out of his templesBase on the fact only 1 person shared results , and the result were meh. I would say dont hold your breath for it.
Is there not systemic absorption though?Absolutely it would. That's why you have hair loss because your gene expression is changed. We're trying to reverse those changes. The consequences of doing this locally in the scalp are nothing but beneficial.
It would be but people are impatient. The GB was pretty big for SMI, if it helps in a major way we'll know it soon enough.Just a question, is it not worth waiting to see what the SMI results are first before adding other stuff?
Or were there no notable results?
So basically even if AR's are degraded throughout the entire body, it doesn't actually have any detrimental side effects that's why they're able to develop this treatment for the prostate.It won't be delivered selectively to the prostate. For that indication it will have systemic side effects because they have to flood your whole body with the compound.
The person to whom you're replying is not arguing that systemic AR degradation is safe, they are saying that the systemic AR degradation resulting from topical application to the scalp is minimal. Since there is no similarly practicable way to deliver a concentrated dose to the prostate, oral administration (which is less selective and thus necessarily causes non-negligible systemic degradation and adverse effects) is needed for people dealing with cancer. That is the typical trade-off when treating cancers with anti-androgens.So basically even if AR's are degraded throughout the entire body, it doesn't actually have any detrimental side effects that's why they're able to develop this treatment for the prostate.
In that case, would oral be superior to topical for hair loss?
Well looks like there's some more context to it than that. I'd seen some posts referencing the fact that most of them ran out of the smi fairly quickly... just because it's been 6months or so since their first group buy it doesn't mean they were using it for 6months.Base on the fact only 1 person shared results , and the result were meh. I would say dont hold your breath for it.
Ah ok I'm understanding now. I was wondering why the company would be developing this for oral delivery if it wasn't safe, but I guess they just expect patients to power thru the sidesThe person to whom you're replying is not arguing that systemic AR degradation is safe, they are saying that the systemic AR degradation resulting from topical application to the scalp is minimal. Since there is no similarly practicable way to deliver a concentrated dose to the prostate, oral administration (which is less selective and thus necessarily causes non-negligible systemic degradation and adverse effects) is needed for people dealing with cancer. That is the typical trade-off when treating cancers with anti-androgens.